Tenon Medical, Inc. (TNON)
| Market Cap | 3.92M -42.5% |
| Revenue (ttm) | 4.60M +40.0% |
| Net Income | -12.42M |
| EPS | -1.33 |
| Shares Out | 17.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 644,005 |
| Open | 0.2305 |
| Previous Close | 0.2305 |
| Day's Range | 0.2210 - 0.2378 |
| 52-Week Range | 0.2200 - 2.4800 |
| Beta | 1.36 |
| Analysts | Buy |
| Price Target | 2.63 (+1,065.26%) |
| Earnings Date | Aug 12, 2026 |
About TNON
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along it... [Read more]
Financial Performance
In 2025, Tenon Medical's revenue was $3.94 million, an increase of 20.35% compared to the previous year's $3.28 million. Losses were -$12.56 million, -8.17% less than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for TNON stock is "Buy." The 12-month stock price target is $2.63, which is an increase of 1,065.26% from the latest price.
News
Tenon Medical announces FDA 510k clearance for Catamaran system
Tenon Medical (TNON) announced it has received U.S. Food and Drug Administration, FDA, 510(k) clearance for its Catamaran SI Joint Fusion System. The updated clearance incorporates various instrument ...
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System
~ Updated clearance incorporates various instrument upgrades, as well as per-procedure costs, improving unit economics driven by the reclassification of certain instruments from disposable to reusable...
WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering
JERSEY CITY, N.J., July 1, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: T...
Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering
LOS GATOS, CA / ACCESS Newswire / July 1, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-p...
WallachBeth Capital Announces Pricing of Tenon Medical, Inc. $4.2 Million Public Offering
JERSEY CITY, N.J., June 30, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ:T...
Tenon Medical prices 11.05M shares at 38c in public offering
Tenon Medical (TNON) has priced a public offering of securities as described below for aggregate gross proceeds to the Company of approximately $4.2M, before deducting placement agent fees and other…
Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering
LOS GATOS, CA / ACCESS Newswire / June 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-...
Tenon Medical Registration statement: Registration filing
Tenon Medical filed a registration statement on June 26, 2026, providing details about a securities offering with the SEC.
Tenon Medical Proxy statement: Proxy filing
Tenon Medical filed a proxy statement on June 23, 2026, providing details for shareholder voting and corporate governance matters.
Tenon Medical files to sell 1.81M shares of common stock
WallachBeth Capital is acting as manager.
Why Is Penny Stock Tenon Medical (TNON) Up Today?
Tenon Medical stock soared on Monday with heavy trading despite listing concerns.
Tenon Medical Registration statement: Registration filing
Tenon Medical filed a registration statement on June 22, 2026, providing details about a securities offering with the SEC.
Tenon Medical Registration statement: Registration filing
Tenon Medical filed a registration statement on June 22, 2026, providing details about a securities offering with the SEC.
Tenon Medical Proxy statement
Tenon Medical filed a proxy statement on June 12, 2026, providing details for shareholder voting and corporate governance matters.
Tenon Medical price target lowered to $2.25 from $2.50 at Alliance Global
Alliance Global analyst Scott Henry lowered the firm’s price target on Tenon Medical (TNON) to $2.25 from $2.50 and keeps a Buy rating on the shares. The firm notes Tenon…
Tenon Medical Earnings Call Transcript: Q1 2026
Record Q1 revenue nearly doubled year-over-year, with gross margin up 24 points to 68.5%. Strong growth in both Catamaran and SImmetry+ platforms, expanded IP, and a strengthened balance sheet position the company for continued margin expansion and new product launches.
Tenon Medical Earnings release: Q1 2026
Tenon Medical released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Tenon Medical Quarterly report: Q1 2026
Tenon Medical has published its Q1 2026 quarterly earnings report on May 12, 2026.
Tenon(R) Medical Reports First Quarter 2026 Financial Results
~ First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~ ~ First Quarter Gross Profit of $0.9 Million, an Increase of Approximately 193% Compared to Prio...
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings
LOS GATOS, CA / ACCESS Newswire / May 1, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announ...
Tenon Medical Earnings Call Transcript: Q4 2025
Record 2025 revenue rose 20% year-over-year, with Q4 up 92% on strong adoption of Catamaran and SImmetry+. Gross margin improved to 69% in Q4, and new FDA clearance plus $7.15M in financing support growth plans for 2026.
Tenon Medical Annual report: Q4 2025
Tenon Medical has published its Q4 2025 annual report on March 19, 2026.
Tenon Medical Earnings release: Q4 2025
Tenon Medical released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.
Tenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial Results
~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~ ~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second H...
WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million
JERSEY CITY, N.J., March 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Tenon Medical, Inc. (NAS...